Jejurikar Shailesh's Form 4 filing
Procter & Gamble Co (PG) · filed Aug 18, 2022
- Accession no.
- 0001127602-22-021278
- Filed
- Aug 18, 2022
- Trade date
- Aug 15-17, 2022
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.86M. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jejurikar ShaileshCIK 0001746310 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 | Common Stock | AGrant or awardAcquired | +31,407 | $0.00F1 | $0 | 31,686.29 | Direct | |
| Aug 17, 2022 | Common Stock | SSaleDisposed | −12,426 | $149.33 | −$1,855,574.58 | 19,260.29 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2022 | Common Stock | AGrant or awardAcquired | +18.69 | $0.00 | $0 | 235.58 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan.
Referenced by the price of 1 transaction in Table I.